Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3104)
All Articles published online
|
Nov 1, 2004 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou YJ, Xiong YX, Wu XT, Shi D, Fan W, Zhou T, Li YC, Huang X. Inactivation of PTEN is associated with increased angiogenesis and VEGF overexpression in gastric cancer. World J Gastroenterol 2004; 10(21): 3225-3229 [PMID: 15457582 DOI: 10.3748/wjg.v10.i21.3225] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i21/3225.htm |
| Number | Citing Articles |
| 1 |
Jianjun Shen, Weina Niu, Hongbo Zhang, Ma Jun, Hongyan Zhang. Downregulation of MicroRNA-147 Inhibits Cell Proliferation and Increases the Chemosensitivity of Gastric Cancer Cells to 5-Fluorouracil by Directly Targeting PTEN. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(6): 901 doi: 10.3727/096504017X15061902533715
|
| 2 |
Satoshi Anai, Steve Goodison, Kathleen Shiverick, Kenneth Iczkowski, Motoyoshi Tanaka, Charles J. Rosser. Combination ofPTENGene Therapy and Radiation Inhibits the Growth of Human Prostate Cancer Xenografts. Human Gene Therapy 2006; 0(0): 060919113707002 doi: 10.1089/hum.2006.17.ft-244
|
| 3 |
Satoshi Anai, Steve Goodison, Kathleen Shiverick, Kenneth Iczkowski, Motoyoshi Tanaka, Charles J. Rosser. Combination of PTEN Gene Therapy and Radiation Inhibits the Growth of Human Prostate Cancer Xenografts. Human Gene Therapy 2006; 17(10): 975 doi: 10.1089/hum.2006.17.975
|
| 4 |
Susy M. E. Scholl, Gemma Kenter, Christian Kurzeder, Philippe Beuzeboc. Pathway Profiling and Rational Trial Design for Studies in Advanced Stage Cervical Carcinoma: A Review and a Perspective. ISRN Oncology 2011; 2011: 1 doi: 10.5402/2011/403098
|
| 5 |
A.F.C. Okines, D. Gonzalez de Castro, D. Cunningham, I. Chau, R.E. Langley, L.C. Thompson, S.P. Stenning, C. Saffery, Y. Barbachano, F. Coxon, G. Middleton, D. Ferry, T. Crosby, S. Madhusudan, J. Wadsley, J. Waters, M. Hall, D. Swinson, A. Robinson, D. Smith, J.S. Reis-Filho, T.S. Waddell, L. Puckey, S. Hulkki Wilson, Z. Eltahir, M. Band, A. Wotherspoon. Biomarker analysis in oesophagogastric cancer: Results from the REAL3 and TransMAGIC trials. European Journal of Cancer 2013; 49(9): 2116 doi: 10.1016/j.ejca.2013.02.007
|
| 6 |
Oguz Kara, Berna Bozkurt Duman, Banu Kara, Seyda Erdogan, Cem Kaan Parsak, Gurhan Sakman. Analysis of PTEN, VEGF, HER2 and P53 Status in Determining Colorectal Cancer Benefit from Bevacizumab Therapy. Asian Pacific Journal of Cancer Prevention 2012; 13(12): 6397 doi: 10.7314/APJCP.2012.13.12.6397
|
| 7 |
Petra Kupsch, Bernhard F. Henning, Katrin Passarge, Heike Richly, Katrin Wiesemann, Ralf A. Hilger, Max E. Scheulen, Olaf Christensen, Erich Brendel, Brian Schwartz, Elke Hofstra, Rudolf Voigtmann, Siegfried Seeber, Dirk Strumberg. Results of a Phase I Trial of Sorafenib (BAY 43-9006) in Combination with Oxaliplatin in Patients with Refractory Solid Tumors, Including Colorectal Cancer. Clinical Colorectal Cancer 2005; 5(3): 188 doi: 10.3816/CCC.2005.n.030
|
| 8 |
Boqing Li, Yunqiu Du, Jing He, Xin Lv, Sisi Liu, Xiaolin Zhang, Ying Zhang. Chloroquine inhibited Helicobacter pylori-related gastric carcinogenesis by YAP–β-catenin–autophagy axis. Microbial Pathogenesis 2023; 184: 106388 doi: 10.1016/j.micpath.2023.106388
|
| 9 |
Andrzej S. Tarnawski, Rama Pai, Tetsuya Tanigawa, Tamara Matysiak-Budnik, Amrita Ahluwalia. PTEN silencing reverses aging-related impairment of angiogenesis in microvascular endothelial cells. Biochemical and Biophysical Research Communications 2010; 394(2): 291 doi: 10.1016/j.bbrc.2010.02.161
|
| 10 |
Christopher C. Uzoh, Claire M. Perks, Amit Bahl, Jeff M.P. Holly, Marto Sugiono, Raj A. Persad. PTEN‐mediated pathways and their association with treatment‐resistant prostate cancer. BJU International 2009; 104(4): 556 doi: 10.1111/j.1464-410X.2009.08411.x
|
| 11 |
Yurdanur Sullu, Seda Gun, Sinan Atmaca, Filiz Karagoz, Bedri Kandemir. Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx. Diagnostic Pathology 2010; 5(1) doi: 10.1186/1746-1596-5-35
|
| 12 |
Chiara Bazzichetto, Fabiana Conciatori, Matteo Pallocca, Italia Falcone, Maurizio Fanciulli, Francesco Cognetti, Michele Milella, Ludovica Ciuffreda. PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?. Cancers 2019; 11(4): 435 doi: 10.3390/cancers11040435
|
| 13 |
Seyed Amir Miratashi Yazdi, Fatemeh Hoseini, Arezoo Eftekhar Javadi, Elham Nazar. Evaluation of phosphatase and tensin homologue (PTEN) expression in gastric cancer and its relationship with histopathological findings. Revista Española de Patología 2024; 57(1): 3 doi: 10.1016/j.patol.2023.11.001
|
| 14 |
M. Katie Conley-LaComb, Wei Huang, Shihua Wang, Dongping Shi, Young Suk Jung, Abdo Najy, Rafael Fridman, R. Daniel Bonfil, Michael L. Cher, Yong Q. Chen, Hyeong-Reh Choi Kim. PTEN Regulates PDGF Ligand Switch for β-PDGFR Signaling in Prostate Cancer. The American Journal of Pathology 2012; 180(3): 1017 doi: 10.1016/j.ajpath.2011.11.021
|
| 15 |
Hester van Cruijsen, Giuseppe Giaccone, Klaas Hoekman. Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies. International Journal of Cancer 2005; 117(6): 883 doi: 10.1002/ijc.21479
|
| 16 |
Stephen R. Wedge, Juliane M. Jürgensmeier. Tumor Angiogenesis. 2008; : 395 doi: 10.1007/978-3-540-33177-3_23
|
| 17 |
Shin Saito, Yoshinori Hosoya, Toru Zuiki, Masanobu Hyodo, Alan Lefor, Naohiro Sata, Michitaka Nagase, Masanori Nakazawa, Daisuke Matsubara, Toshiro Niki, Yoshikazu Yasuda. A clinicopathological study of basaloid squamous carcinoma of the esophagus. Esophagus 2009; 6(3): 177 doi: 10.1007/s10388-009-0202-3
|
| 18 |
Petros Nikolinakos, John V. Heymach. The Tyrosine Kinase Inhibitor Cediranib for Non-small Cell Lung Cancer and Other Thoracic Malignancies. Journal of Thoracic Oncology 2008; 3(6): S131 doi: 10.1097/JTO.0b013e318174e910
|
| 19 |
Lihua Li, Xiongjie Zhu, Tao Shou, Libo Yang, Xiaozhen Cheng, Jinting Wang, Lian Deng, Yanfang Zheng. MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway. Molecular Medicine Reports 2017; doi: 10.3892/mmr.2017.8299
|
| 20 |
Miriam Stumpf, Sasja Blokzijl-Franke, Jeroen den Hertog, Sheng-Ping Lucinda Hwang. Fine-Tuning of Pten Localization and Phosphatase Activity Is Essential for Zebrafish Angiogenesis. PLOS ONE 2016; 11(5): e0154771 doi: 10.1371/journal.pone.0154771
|
| 21 |
Sormeh Mina, Benjamin A Bohn, Ronald Simon, Antje Krohn, Matthias Reeh, Dirk Arnold, Carsten Bokemeyer, Guido Sauter, Jakob R Izbicki, Andreas Marx, Phillip R Stahl. PTEN deletion is rare but often homogeneous in gastric cancer. Journal of Clinical Pathology 2012; 65(8): 693 doi: 10.1136/jclinpath-2011-200525
|
| 22 |
WEI LI, MEI-LIN LIU, JIA-HUI CAI, YUN-XIAN TANG, LING-YUN ZHAI, JUN ZHANG. Effect of the combination of a cyclooxygenase-1 selective inhibitor and taxol on proliferation, apoptosis and angiogenesis of ovarian cancer in vivo. Oncology Letters 2012; 4(1): 168 doi: 10.3892/ol.2012.688
|
| 23 |
Stephen R. Wedge, Jane Kendrew, Laurent F. Hennequin, Paula J. Valentine, Simon T. Barry, Sandra R. Brave, Neil R. Smith, Neil H. James, Michael Dukes, Jon O. Curwen, Rosemary Chester, Janet A. Jackson, Sarah J. Boffey, Lyndsey L. Kilburn, Sharon Barnett, Graham H.P. Richmond, Peter F. Wadsworth, Mike Walker, Alison L. Bigley, Sian T. Taylor, Lee Cooper, Sarah Beck, Juliane M. Jürgensmeier, Donald J. Ogilvie. AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of Cancer. Cancer Research 2005; 65(10): 4389 doi: 10.1158/0008-5472.CAN-04-4409
|
| 24 |
Miriam Stumpf, Jeroen den Hertog, Irina U Agoulnik. Differential Requirement for Pten Lipid and Protein Phosphatase Activity during Zebrafish Embryonic Development. PLOS ONE 2016; 11(2): e0148508 doi: 10.1371/journal.pone.0148508
|
| 25 |
Dora Fuckar, Andrea Dekanic, Sanja Stifter, Elvira Mustac, Mira Krstulja, Fran Dobrila, Nives Jonjic. VEGF Expression is Associated with Negative Estrogen Receptor Status in Patients with Breast Cancer. International Journal of Surgical Pathology 2006; 14(1): 49 doi: 10.1177/106689690601400109
|
| 26 |
Jin-Kyung Seok, Sun Hee Lee, Min Jung Kim, You-Mie Lee. MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog. Nucleic Acids Research 2014; 42(12): 8062 doi: 10.1093/nar/gku515
|
| 27 |
WEI QU, JIN-DONG FU, FANG YANG, GONG-LI YANG, YA-LI ZHANG, XIN-YING WANG, HONG-XIANG GU, HAI-YAN ZHANG, LING WANG. Clinical implications of PTEN and VEGF expression status, as well as microvessel density in esophageal squamous cell carcinoma. Oncology Letters 2015; 10(3): 1409 doi: 10.3892/ol.2015.3431
|
| 28 |
Alicja Forma, Magdalena Tyczyńska, Paweł Kędzierawski, Klaudyna Gietka, Monika Sitarz. Gastric carcinogenesis: a comprehensive review of the angiogenic pathways. Clinical Journal of Gastroenterology 2021; 14(1): 14 doi: 10.1007/s12328-020-01295-1
|
| 29 |
Yong Xia, Xuejiao Song, Deliang Li, Tinghong Ye, Youzhi Xu, Hongjun Lin, Nana Meng, Guobo Li, Senyi Deng, Shuang Zhang, Li Liu, Yongxia Zhu, Jun Zeng, Qian Lei, Youli Pan, Yuquan Wei, Yinglan Zhao, Luoting Yu. YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models. Scientific Reports 2014; 4(1) doi: 10.1038/srep06031
|